8 May saw construction begin on AstraZeneca’s new small molecule pharmaceutical plant. Since setting up in 1993, AstraZeneca has put US$1 billion into Wuxi, making it HQ for the firm’s production, distribution, sales and innovation in China. Full story (in Chinese) via this link; read lots more of the latest news from Wuxi via this link.